Another study demonstrated that the SFRP1 inhibitor diarylsulfonylsulfonamide can stimulate the Wnt/β-catenin signaling pathway by inhibiting the expression of SFRP1 in U2-OS human osteosarcoma cells [92]. The gene discussed is SFRP1; the disease is osteosarcoma.